article thumbnail

Health Innovators – Dr. Houda Hachad

pharmaphorum

Genetic testing has become vastly more accessible in the last 20 years and has opened all kinds of doors in medicine, from pharmacogenetics and better understanding drug interactions and adverse events to tremendous advances in oncology: understanding the underlying genetics of cancer cells has allowed delivery of affective, targeted treatments.

article thumbnail

Orexo eyes opioid use disorder app launch before year-end

pharmaphorum

“Modia is designed to close the gap as it relates to the access and receipt of quality, evidence-based therapeutic interventions and behavioural health services for individuals with OUD who participate in outpatient treatment with MAT,” said Michael Sumner, Orexo’s chief medical officer.

article thumbnail

Changing Faces: pharma supplier, DTx, and non-profit hires from November 2022

pharmaphorum

Digital therapeutics company Cognoa, which focuses on paediatric behavioural health, announced the appointment of Dr Sharief Taraman as its new CEO. Generative AI drug creation company Absci Corporation has added Dan Rabinovitsj (as pictured), VP of connectivity at Meta, to its Board of Directors. Digital therapeutics hires.